| 000 | 01916 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515190400.0 | ||
| 264 | 0 | _c20091203 | |
| 008 | 200912s 0 0 eng d | ||
| 022 | _a1538-7445 | ||
| 024 | 7 |
_a10.1158/0008-5472.CAN-09-0511 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWahner Hendrickson, Andrea E | |
| 245 | 0 | 0 |
_aExpression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitro. _h[electronic resource] |
| 260 |
_bCancer research _cOct 2009 |
||
| 300 |
_a7635-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBenzimidazoles _xpharmacology |
| 650 | 0 | 4 |
_aCell Growth Processes _xdrug effects |
| 650 | 0 | 4 | _aHL-60 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xbiosynthesis |
| 650 | 0 | 4 | _aK562 Cells |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aProtein Isoforms |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPyridones _xpharmacology |
| 650 | 0 | 4 |
_aReceptor, IGF Type 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptor, Insulin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 | _aU937 Cells |
| 700 | 1 | _aHaluska, Paul | |
| 700 | 1 | _aSchneider, Paula A | |
| 700 | 1 | _aLoegering, David A | |
| 700 | 1 | _aPeterson, Kevin L | |
| 700 | 1 | _aAttar, Ricardo | |
| 700 | 1 | _aSmith, B Douglas | |
| 700 | 1 | _aErlichman, Charles | |
| 700 | 1 | _aGottardis, Marco | |
| 700 | 1 | _aKarp, Judith E | |
| 700 | 1 | _aCarboni, Joan M | |
| 700 | 1 | _aKaufmann, Scott H | |
| 773 | 0 |
_tCancer research _gvol. 69 _gno. 19 _gp. 7635-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-09-0511 _zAvailable from publisher's website |
| 999 |
_c19185589 _d19185589 |
||